Correlation Between Sangamo Therapeutics and Enanta Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Sangamo Therapeutics and Enanta Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sangamo Therapeutics and Enanta Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sangamo Therapeutics and Enanta Pharmaceuticals, you can compare the effects of market volatilities on Sangamo Therapeutics and Enanta Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sangamo Therapeutics with a short position of Enanta Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sangamo Therapeutics and Enanta Pharmaceuticals.

Diversification Opportunities for Sangamo Therapeutics and Enanta Pharmaceuticals

-0.17

Correlation Coefficient

Sangamo Therapeutics  Enanta Pharmaceuticals

Good diversification

The 3 months correlation between Sangamo and Enanta is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Sangamo Therapeutics and Enanta Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enanta Pharmaceuticals and Sangamo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sangamo Therapeutics are associated (or correlated) with Enanta Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enanta Pharmaceuticals has no effect on the direction of Sangamo Therapeutics i.e., Sangamo Therapeutics and Enanta Pharmaceuticals go up and down completely randomly.

Pair Corralation between Sangamo Therapeutics and Enanta Pharmaceuticals

Given the investment horizon of 90 days Sangamo Therapeutics is expected to under-perform the Enanta Pharmaceuticals. In addition to that, Sangamo Therapeutics is 1.69 times more volatile than Enanta Pharmaceuticals. It trades about -0.12 of its total potential returns per unit of risk. Enanta Pharmaceuticals is currently generating about 0.03 per unit of volatility. If you would invest  585.00  in Enanta Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  1.00  from holding Enanta Pharmaceuticals or generate 0.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Sangamo Therapeutics  vs.  Enanta Pharmaceuticals

Sangamo Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sangamo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Enanta Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Enanta Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Enanta Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Sangamo Therapeutics and Enanta Pharmaceuticals

The main advantage of trading using opposite Sangamo Therapeutics and Enanta Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sangamo Therapeutics position performs unexpectedly, Enanta Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enanta Pharmaceuticals will offset losses from the drop in Enanta Pharmaceuticals' long position.

The idea behind Sangamo Therapeutics and Enanta Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.